Don't believe it will be 2nd phase of a Roche deal - Paul Watt talked about that coming near the end of the year.
It will, most likely, be one of the two new deals presaged in various presentations.
Fundamentally, it seems, PYC keeps it's promises.
How many deals does it take to prove the business model?
Once they achieve cash flow neutrality ... we have time to scale the discovery programmes and have time to wait for a drug "blockbuster" to emerge.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.36 |
Change
0.005(0.37%) |
Mkt cap ! $793.2M | |||
| Open | High | Low | Value | Volume |
| $1.40 | $1.40 | $1.36 | $211.9K | 152.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4103 | $1.36 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.39 | 2028 | 1 |
View Market Depth
| Last trade - 16.10pm 18/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |